Drug Research
Singapore Finds A New Treatment Aim For Diabetic Eye Illness
Researchers in Singapore have identified a brand-new therapeutic target called ADAM10 that may be used to treat people who have diabetic retinopathy (DR), a disorder that is brought on by untreated diabetes and results in blindness.
A typical symptom of...
News
Personalized Nutrition Market Growth: An Overview
Personalized nutrition refers to the practice of tailoring dietary plans to an individual's needs rather than the general population's. Customized nutrition plans consider an individual's age, sex, genetics, and health objectives. More people are becoming aware that a one-fit-all...
News
Everything You Need To Know About BCCAs Supplements
BCAA supplements are increasingly gaining popularity amongst athletes and people involved in resistance training. These supplements are typically consumed before, during, or after exercise.
Scientific studies have shown that consuming BCAAs reduces muscle damage and increases muscle protein synthesis.
Here, we...
News
Astellas, 3 Other Companies Collaborate To Reduce Environmental Burden In Field Of Pharma Packaging
Astellas Pharma Inc., Eisai Co., Daiichi Sankyo Company and Takeda Pharmaceutical have agreed on collaboration to reduce environmental burden in the field of pharmaceutical packaging.
Based on the agreement, the four companies will aim to promote the use of more...
News
Rhenus Air & Ocean gains GDP certification at Schiphol Airport
Rhenus Air & Ocean’s pharma-focused business site at Amsterdam Airport Schiphol (AMS) has gained the Good Distribution Practice (GDP) certificate.
The Dutch headquarters of Rhenus, which has been IATA CEIV Pharma accredited for years, follows the footsteps of the business...
Clinical Trials
Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets
Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received approval from Health Canada to initiate its Phase 1/2a study evaluating the safety, tolerability, bioavailabilty...
News
KangaBio and Aton Biotech Enter Into Development and Manufacturing Strategic Collaboration
Aton Biotech, a CDMO committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform, and KangaBio have announced a strategic collaboration.
Both parties aim to share resources and achieve joint development on the principle of equality and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read